BlackRock’s Vaxart VXRT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-1,774,346
| Closed | -$802K | – | 5616 |
|
|
2025
Q2 | $802K | Sell |
1,774,346
-9,883
| -0.6% | -$4.3K | ﹤0.01% | 4322 |
|
|
2025
Q1 | $726K | Sell |
1,784,229
-215,555
| -11% | -$138K | ﹤0.01% | 4286 |
|
|
2024
Q4 | $1.32M | Buy |
1,999,784
+225,438
| +13% | +$157K | ﹤0.01% | 4153 |
|
|
2024
Q3 | $1.51M | Hold |
1,774,346
| – | – | ﹤0.01% | 4082 |
|
|
2024
Q2 | $1.18M | Hold |
1,774,346
| – | – | ﹤0.01% | 4134 |
|
|
2024
Q1 | $2.31M | Sell |
1,774,346
-15,118
| -0.8% | -$15.8K | ﹤0.01% | 3963 |
|
|
2023
Q4 | $1.03M | Hold |
1,789,464
| – | – | ﹤0.01% | 4246 |
|
|
2023
Q3 | $1.35M | Sell |
1,789,464
-139,245
| -7% | -$106K | ﹤0.01% | 4145 |
|
|
2023
Q2 | $1.41M | Sell |
1,928,709
-6,889,938
| -78% | -$6.4M | ﹤0.01% | 4188 |
|
|
2023
Q1 | $6.67M | Sell |
8,818,647
-39,578
| -0.4% | -$36.8K | ﹤0.01% | 3512 |
|
|
2022
Q4 | $8.51M | Sell |
8,858,225
-254,780
| -3% | -$360K | ﹤0.01% | 3469 |
|
|
2022
Q3 | $19.9M | Sell |
9,113,005
-71,228
| -0.8% | -$246K | ﹤0.01% | 3032 |
|
|
2022
Q2 | $32.1M | Buy |
9,184,233
+741,604
| +9% | +$2.77M | ﹤0.01% | 2795 |
|
|
2022
Q1 | $42.6M | Sell |
8,442,629
-9,791
| -0.1% | -$49.6K | ﹤0.01% | 2679 |
|
|
2021
Q4 | $53M | Buy |
8,452,420
+357,036
| +4% | +$2.44M | ﹤0.01% | 2626 |
|
|
2021
Q3 | $64.4M | Sell |
8,095,384
-73,789
| -0.9% | -$607K | ﹤0.01% | 2498 |
|
|
2021
Q2 | $61.2M | Buy |
8,169,173
+2,751,257
| +51% | +$19.2M | ﹤0.01% | 2565 |
|
|
2021
Q1 | $32.8M | Buy |
5,417,916
+481,357
| +10% | +$3.7M | ﹤0.01% | 2894 |
|
|
2020
Q4 | $28.2M | Buy |
4,936,559
+662,889
| +16% | +$4.22M | ﹤0.01% | 2827 |
|
|
2020
Q3 | $28.4M | Buy |
4,273,670
+907,013
| +27% | +$8.08M | ﹤0.01% | 2661 |
|
|
2020
Q2 | $29.8M | Buy |
3,366,657
+2,849,025
| +550% | +$8.18M | ﹤0.01% | 2586 |
|
|
2020
Q1 | $916K | Buy |
517,632
+477,223
| +1,181% | +$608K | ﹤0.01% | 3898 |
|
|
2019
Q4 | $15K | Hold |
40,409
| – | – | ﹤0.01% | 4698 |
|
|
2019
Q3 | $15K | Hold |
40,409
| – | – | ﹤0.01% | 4681 |
|
|
2019
Q2 | $27K | Sell |
40,409
-10,839
| -21% | -$9.08K | ﹤0.01% | 4651 |
|
|
2019
Q1 | $99K | Sell |
51,248
-742
| -1% | -$1.41K | ﹤0.01% | 4384 |
|
|
2018
Q4 | $98K | Sell |
51,990
-212
| -0.4% | -$631 | ﹤0.01% | 4357 |
|
|
2018
Q3 | $149K | Buy |
52,202
+477
| +0.9% | +$1.45K | ﹤0.01% | 4383 |
|
|
2018
Q2 | $157K | Buy |
51,725
+11,316
| +28% | +$52.2K | ﹤0.01% | 4371 |
|
|
2018
Q1 | $215K | Sell |
40,409
-3,874
| -9% | -$25K | ﹤0.01% | 4197 |
|
|
2017
Q4 | $275K | Buy |
44,283
+107
| +0.2% | +$748 | ﹤0.01% | 4153 |
|
|
2017
Q3 | $333K | Buy |
44,176
+182
| +0.4% | +$1.24K | ﹤0.01% | 4129 |
|
|
2017
Q2 | $324K | Sell |
43,994
-9,686
| -18% | -$57.9K | ﹤0.01% | 4130 |
|
|
2017
Q1 | $385K | Buy |
+53,680
| New | +$549K | ﹤0.01% | 4037 |
|
|
2016
Q4 | – | Hold |
0
| – | – | – | 3819 |
|
|
2016
Q3 | – | Hold |
0
| – | – | – | 3760 |
|
|
2016
Q2 | – | Hold |
0
| – | – | – | 3830 |
|
|
2014
Q4 | – | Sell |
-11,173
| Closed | -$304K | – | 3194 |
|
|
2014
Q3 | $304K | Sell |
11,173
-909
| -8% | -$26.1K | ﹤0.01% | 1427 |
|
|
2014
Q2 | $379K | Hold |
12,082
| – | – | ﹤0.01% | 1378 |
|
|
2014
Q1 | $812K | Hold |
12,082
| – | – | ﹤0.01% | 1249 |
|
|
2013
Q4 | $557K | Buy |
+12,082
| New | +$532K | ﹤0.01% | 1330 |
|
Other funds holding VXRT
XT
HSA
BCMLT
CFO
LCM
HWA
BlackRock's VXRT Position: Q3 2025 in Review
BlackRock sold out of Vaxart (VXRT) in Q3 2025, closing a stake of 1,774,346 shares — an estimated $802K sold.
BlackRock first reported a position in VXRT in Q4 2013 and held it in 38 quarters. The position peaked at $64.4M in Q3 2021. 17 funds tracked by Wall St. Rank hold VXRT as of Q3 2025.
- BlackRock reported no remaining Vaxart position as of Q3 2025 after selling out during the quarter.
- BlackRock sold 1,774,346 Vaxart shares in Q3 2025, an estimated $802K.
- BlackRock first reported a position in Vaxart in Q4 2013 and held it in 38 quarters.
- BlackRock's Vaxart position peaked at $64.4M in Q3 2021.
- 17 funds tracked by Wall St. Rank held Vaxart as of Q3 2025.
Based on BlackRock's 13F filing for Q3 2025, filed 12 Nov 2025.